Skip to content
AI IntelligenceMay 15, 2026AI Intelligence
Article

TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results.

The company is developing novel therapies to overcome resistance to cancer immunotherapy.

Data Cube AI EditorialSource: PR Newswire
01

Source Brief

TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results. The company is developing novel therapies to overcome resistance to cancer immunotherapy.